Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q3 2021 Results - Earnings Call Transcript

Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q3 2021 Results - Earnings Call Transcript

SeekingAlpha

Published